. Furthermore, we show that E1A binding to CtBP is NAD ϩ dependent, requiring active site residues and a this interaction is specific to the PXDLS motif of E1A, as a peptide containing this motif is able to effectively functional dimer. The catalytic residues are also required for RIP140-dependent repression of retinoic acid recepcompete with this interaction. Thus, the dehydrogenase domain of CtBP is sufficient to interact with PXDLS motif tor (RAR). Together, these initial structural and biochemical results suggest an allosteric mechanism for recruitand mediate functional repression. ment of CtBP to its consensus recognition motif for specific repression events in cells.
Structure of CtBP
Given that the dehydrogenase domain of CtBP is a funcResults tional dehydrogenase and that it alone mediates repression, we set out to determine its structure. We expressed CtBP Is a Functional Dehydrogenase and purified the 28-353 residue minimal domain from We first asked whether CtBP is a functional dehydrogebacteria in the presence of NAD ϩ , and crystals of the nase. Dehydrogenase activity can be assayed by quanticomplex were obtained from solutions containing sotating change of NADH to NAD ϩ or vise versa, which dium formate and magnesium acetate. The structure can be monitored by loss or gain of absorbance at 340 was solved by multiwavelength anomalous diffraction nm (Adams et al., 1973) . Most dehydrogenases have a (MAD) method (Hendrickson, 1991) using selenomethiostrict substrate specificity; however, they will catalyze nine-labeled protein expressed in a strain of E.coli that nonoptimal substrates at slower rates. We used an is methionine auxotrophic ( Table 1 ). The current model, assay that coupled the reduction of pyruvate to lactic refined to 1.95 Å resolution, includes residues 28-352 acid with the oxidation of NADH to NAD ϩ . For these with good stereochemistry. The crystallographic asymexperiments we purified CtBP from baculovirus-infected metric unit contains a CtBP monomer that forms exten-SF9 cells, yielding essentially a homogenous protein sive dimer contacts with a crystallographic 2-fold related ( Figure 1C ). CtBP was able to catalyze this reaction in copy. a dose-dependent manner ( Figure 1A) . Even though the CtBP is thus a dimer, where each monomer is divided reaction was inefficient, it is specific to CtBP, as both an into large and small domains separated by a flexible equivalent volume of uninfected SF9 cell extract (Figure hinge region (Figure 2) . A cleft at the confluence of the 1B), and a catalytic site mutant of CtBP ( Figure 6D ) two domains provides binding sites for NAD ϩ as well were not able to catalyze the reaction. In addition, the as a putative substrate. Because all of the NAD ϩ binding reactions required the presence of pyruvate, demonstraresidues stem from the large domain, it has been called ting that the substrate is not CtBP itself, anything in the the NAD ϩ or coenzyme binding domain in previous D2-SF9 extract, or buffer ( Figure 1B ). Thus using a nonopti-HDH structures. The small domain will be referred to as mal substrate, we were able to demonstrate that CtBP the substrate binding domain, which is globular in shape is a functional dehydrogenase.
‫23ف(‬ ϫ 25 ϫ 29 Å ) and composed of residues from both the N (aa 27-121) and C terminus (aa 327-352). The NAD ϩ binding domain is contiguous in polypeptide (aa 125-318), The Dehydrogenase Domain Alone Is a Repressor All but the last 90 aa of 440 residue hCtBP1 has signifielongated in shape ‫35ف(‬ ϫ 33 ϫ 39 Å ), and mediates most of the dimerization contacts (Figure 2 ). The dimercant homology to D2-HDHs. Having shown that CtBP is a functional dehydrogenase, we sought to determine ization interface is extensive, burying ‫8633ف‬ Å 2 of solvent accessible surface area per monomer ( Figure 2B) Figure 1D, compare lanes 2 and 3) , and the last 90 aa of CtBP1 (CЈ) has no significant repressive 1996), composed of a parallel ␤ sheet (␤A-␤G) flanked on both sides by ␣ helices (␣A-␣H). The connectivity activity in this assay ( Figure 1D, lane 4) . In another assay, we used CtBP to repress Gal4DBD/E1A-mediated actiresembles a Rossmann or a dinucleotide binding fold that occurs widely in NAD ϩ -dependent dehydrogenases vation from a UAS/tk luciferase. We also used the CЈ (last 78 aa) of E1A, which was used to clone CtBP in a (Rao and Rossmann, 1973). This similarity in connectivity reflects the maintenance of residues mediating NAD substrate binding domain is more variable with rmsds adenine moiety is oriented toward the entrance to the cleft while the nicotinamide ring is more deeply buried ranging from 1.3 to 1.65 Å . This variability is further enhanced by loops extending into the active site cleft, toward the substrate binding pocket (Figure 2A ure 3A). The structure reveals why glycines at positions can be derived in which Arg97 and Ser100 form hydrogen bonds with the terminal carboxylate group, and 181 and 183 (GXGXXG(17X)D) are critical for NAD ϩ binding, since substitution by any other amino acids at these Arg266 is in a position to form a bond with the 2-hydroxyl. Interestingly, Arg97 and Ser100 are primarily hydrophopositions would cause steric clashes with the bridging pyrophosphate bridge. The adenine is nestled in a hybic residues in other D2-HDHs. In D2-HicDH, the terminal carboxylate is instead recognized by Tyr100, which drophobic cavity defined by residues Pro205 and Tyr206, with its N7 atom accepting a hydrogen bond from Asn240 is an alanine (Ala123) in CtBP ( Figure 3B ). Thus, CtBP may use a different set of amino acids to fix the orienta-( Figure 3A) .
A His/Glu(Asp)/Arg triad is conserved in all D2-HDHs tion of a D-2-hydroxyacid substrate in its active site as compared to other D2-HDHs. His315 and Arg266 and implicated as the center for substrate binding and dehydrogenase activity. The structurally equivalent resiare Ͻ4 Å from the 2-hydroxyl group of the modeled substrate. The aliphatic portion of modeled 2-oxoisocadues in CtBP are His315, Glu295, and Arg266. The histidine is postulated to be the acid/base catalyst, with proate clashes with Trp318 that emanates from the CtBP NAD ϩ binding domain and His77 that extends from the the glutamate/aspartate helping to lower the pKa of the histidine to stabilize it in a protonated state. The arginine substrate binding domain. Both of these residues are unique to CtBP and probably contribute to its substrate is proposed to polarize the 2-hydroxyl of the substrate for catalysis. While a biologically relevant substrate for specificity ( Figure 3B ). The steric clashes with these residues suggest that CtBP probably binds a 2-hydroxyCtBP remains to be identified, the structure provides valuable insights into the nature of a putative substrate. acid substrate that is somewhat smaller in the "R" group than D-2-hydroxyisocaproate. Also, the lack of basic In particular, a superposition with D2-HicDH/NAD tional change further, we undertook limited proteolysis dimerization function (Dim mut ), and a cavity at one end of active site cleft (Cleft mut ). The mutations included D204A, of TnT CtBP in the absence and presence of varying G181V, and G183V for NAD mut , and H315A, E295A, concentrations of NAD ϩ and NADH. The digestion was R266A, and D290A for Cat mut . Because of the extensive carried out with the nonspecific protease papain that dimer interface two sets of mutations were generated: has been used widely to probe the configuration of mod-R141A, R142A, R163A, and R171A to disrupt critical ular proteins. CtBP in the presence of NAD(H) is resistant salt links and hydrogen bonding across the interface to papain digestion, producing a very stable ‫04ف‬ kDa (Dim1 mut ), and C134Y, N138R, R141E, and L150W to infragment, which we used as qualitative assay for NAD(H)-troduce steric and electrostatic repulsion across the dependent conformational change ( Figure 5G ). Using interface (Dim2 mut ). Cleft mut included K108A, F102A, and this assay, we determined the concentration of NAD ϩ I107A mutations to disrupt residues lining a cavity near and NADH at which the resistant 40 kDa fragment was the entrance to the active site cleft that we initially specproduced. Consistent with our E1A binding data, the ulated might interact with the PXDLS motif (Figures 2B protease digestion showed a conformational switch beand 4B). As expected, NAD mut strongly inhibited CtBP's tween 1 and 10 M NAD ϩ and NADH, with both comability to bind E1A ( Figure 5A ), consistent with the NAD ϩ / pounds behaving identically ( Figure 5G ). Thus using two NADH dependency observed above with the native enindependent assays, we could not detect any difference zyme. Unexpectedly, however, Cat mut and Dim mut also in NAD ϩ -and NADH-induced conformational change of severely compromised the ability of CtBP to bind E1A, CtBP translated in an in vitro mammalian system. while Cleft mut did not affect interaction with E1A ( Figure  5A the active site residues. His315, Glu295, and Arg266 lie CtBP mutants that were impaired in E1A binding were also defective in repression, we measured CtBP-depenat the confluence of the NAD ϩ and substrate binding domains and are in positions to interact with both a dent repression of Gal4/E1A on a UAS-tk-dependent reporter. Each set of mutations, except Cleft mut , impaired buried substrate and a PXDLS peptide segment at the rim of the active site cleft (Figures 3B and 4B) . Interestthe ability of expressed CtBP to repress Gal4/E1A, consistent with a failure to recruit E1A ( Figure 5B) . Moreover, ingly, the active site cleft in the vicinity of His315, Glu295, and Arg266 is bordered by a loop from the 2-fold related when the mutant CtBP proteins were expressed at very high levels, they were able to repress Gal4/E1A, alCtBP subunit that could make additional contacts with the PXDLS motif ( Figure 4B) (Zhang et al., 2000) , prompted us to test the requirement pressed in inclusion bodies in E. coli that limited their biophysical analysis. As another measure of structure, for the catalytic residues of CtBP during repression by nuclear receptor. We found that increasing the levels we carried out partial proteolytic digestion of 35 S-labeled TnT mutant proteins in the apo form ( Figure 6B ). All the of CtBP causes a complete block of ligand-dependent activation by retinoic acid receptor ( Figure 5C ). Howmutants, including NAD mut and Dim1 mut , showed similar pattern of papain digestion as wild-type CtBP. We next ever, mutations of the catalytic residues (Cat mut ) abolished the ability of CtBP to induce repression, consistent showed that the Cat mut was indeed defective in catalysis using the same pyruvate to lactic acid, coupled with with a role for this domain in recruitment of CtBP to the RAR activation complex. To determine whether this was NADH to NAD ϩ assay ( Figure 6C ). We also carried out GST pull-down experiments with S 35 -labeled TnT Dim1 mut dependent upon RIP140, the ability of a specific ␣RIP140 IgG to block CtBP-dependent repression was evaluated (and Dim2 mut ) that is consistent with a lack of ability to dimerize ( Figure 6D ). We used the proteolysis assay to using single-cell microinjection assay. We found that injecting ␣RIP140 antibody fully restored the ligandshow that the NAD mut does not bind NAD ϩ ( Figure 6E ). As mentioned earlier, upon NAD ϩ binding, there is a dependent activation and that the ␣RIP140 antibody had no effect on unliganded retinoic acid receptor tranprotease-resistant 40 kDa fragment of CtBP that is produced ( Figure 6E , compare left panel, lanes 1 and 2); scription unit ( Figure 5D ). Thus, CtBP domains exhibited similar behavior for both E1A and RIP140-dependent however, there is no such band in NAD mut in the presence of NAD ϩ ( Figure 6E , compare right panel, lanes 1 and repression events. Our results provide evidence that CtBP is a functional dehydrogenase and that it utilizes 2). In all, these biophysical and biochemical control experiments establish the structural integrity of the mutant its dehydrogenase domain to bind to its recognition motif.
proteins in assessing E1A binding in vitro and in vivo.
Discussion

Biophysical and Biochemical Characterization of the Mutant Proteins
The mutations above were designed on the basis of the The switch between transcriptional repression and transcriptional activation has been the subject of intensive crystal structure to lie outside of the hydrophobic core, so as to preserve structure. The dimerization mutations investigation over the past 7 years, and one of the most intriguing aspects involves the identification of a number were similarly designed to disrupt the dimer interface but not the monomeric structure. We confirmed the foldof enzymatic activities that underlie these events ( Figure 6A ). The depth of the 222 nm minimum has prompted the speculation that CtBP might contribute another important enzymatic activity to corepressor is in approximate agreement with the helicity calculated from the crystal structure ‫%14ف(‬ helicity). We tested complexes. Here, we provide biochemical and structural evidence that CtBP is indeed a functional dehydrogedimerization capability by subjecting the dehydrogenase domains of Cat mut and Dim2 mut to analytical ultranase, with a characteristic dumbbell shape and an active site cleft for NAD ϩ and substrate binding. The dehydrocentrifugation (AU). Equilibrium sedimentation data for Cat mut provided a molecular mass ‫47ف(‬ kDa) that is in genase domain alone is sufficient to mediate repression and can bind the PXDLS recognition sequence motif good agreement with the calculated size of a CtBP dehydrogenase domain dimer with an N-terminal his-tag of E1A in an NAD ϩ -dependent "closed" conformation. While a true substrate for CtBP remains to be identified, ‫67ف(‬ kDa). Dim2 mut , however, could not be reliably analyzed by equilibrium sedimentation because the protein steric features of the substrate binding pocket suggest a D2-hydroxyacid with a small "R" group and the lack had a small tendency to precipitate over the long time period (13 hr) of data collection. Instead, we compared of a phosphate group. CtBP has also been identified as brefeldin A ribosylaDim2 mut and Cat mut by sedimentation velocity measurements with scans taken every 1 min over a period of 3 tion substrate (BARS50), whose LPA acyltransferase function is essential for Golgi maintenance ( is used to acylate lysophosphatidic acid to phosphatidic PXDLS motif. In Drosophila, there are three splice variants of CtBP differing only in the CЈ, and the shortest acid. It is not easy to see from our structure how both lysophosphatidic acid and acyl-CoA can be accommoof these splice variants is essentially only composed of the dehydrogenase domain (Poortinga et al., 1998). We dated within the CtBP dehydrogenase active site. Moreover, the structure shows little relationship to that of initially speculated, based on the crystal structure, that the PXDLS motif might bind in a cavity near the entrance glycerol-3-phosphate (1)-acyltransferase (Turnbull et al., 2001), which catalyzes an acyl-transfer reaction similar to the active site cleft. However, mutations in this cavity do not disrupt E1A interactions in vitro or the repression to that proposed for CtBP/BARS in the Golgi. However CtBP could carry out an NAD ϩ -dependent oxidation/ function in vivo. Unexpectedly, mutation of the active site residues do affect E1A binding, suggesting that reduction reaction in the Golgi that is more consistent with our structure. This could be true for both BARS50 the PXDLS motif interacts with these residues at the periphery of the active site cleft. The cleft is walled off as well as RIBEYE, which is a splice variation of CtBP2 consisting of an N terminus extension, found in synby a loop extending from the 2-fold related subunit that may provide additional interactions with the PXDLS seapses but whose function is unknown.
We show here that the dehydrogenase domain alone quence. Indeed, CtBP may be a simple dehydrogenase that has evolved or gained an extra ability to bind a is sufficient to bind the PXDLS motif. This domain is highly conserved within CtBP family members from C.
PXDLS recognition motif. The p140 is highly recruited to ligand receptors on elegans to vertebrates. However the C terminus extension ( 
